These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27872069)

  • 1. Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects.
    Yee KL; Sanchez RI; Auger P; Liu R; Fan L; Triantafyllou I; Lai MT; Di Spirito M; Iwamoto M; Khalilieh SG
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
    Anderson MS; Khalilieh S; Yee KL; Liu R; Fan L; Rizk ML; Shah V; Hussaini A; Song I; Ross LL; Butterton JR
    Clin Pharmacokinet; 2017 Jun; 56(6):661-669. PubMed ID: 27699622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects.
    Anderson MS; Gilmartin J; Cilissen C; De Lepeleire I; Van Bortel L; Dockendorf MF; Tetteh E; Ancona JK; Liu R; Guo Y; Wagner JA; Butterton JR
    Antivir Ther; 2015; 20(4):397-405. PubMed ID: 25470746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study.
    Khalilieh S; Yee KL; Sanchez RI; Triantafyllou I; Fan L; Maklad N; Jordan H; Martell M; Iwamoto M
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine.
    Boyle A; Moss CE; Marzolini C; Khoo S
    Clin Pharmacokinet; 2019 Dec; 58(12):1553-1565. PubMed ID: 31388941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gender and age on the relative bioavailability of doravirine: results of a Phase I trial in healthy subjects.
    Behm MO; Yee KL; Fan L; Fackler P
    Antivir Ther; 2017; 22(4):337-344. PubMed ID: 28206979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics.
    Ankrom W; Yee KL; Sanchez RI; Adedoyin A; Fan L; Marbury T; Preston RA; Iwamoto M; Khalilieh SG
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.
    Khalilieh S; Yee KL; Liu R; Fan L; Sanchez RI; Auger P; Triantafyllou I; Stypinski D; Lasseter KC; Marbury T; Iwamoto M
    J Clin Pharmacol; 2017 Jun; 57(6):777-783. PubMed ID: 28026013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.
    Yee KL; Khalilieh SG; Sanchez RI; Liu R; Anderson MS; Manthos H; Judge T; Brejda J; Butterton JR
    Clin Drug Investig; 2017 Jul; 37(7):659-667. PubMed ID: 28353169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
    Schürmann D; Sobotha C; Gilmartin J; Robberechts M; De Lepeleire I; Yee KL; Guo Y; Liu R; Wagner F; Wagner JA; Butterton JR; Anderson MS
    AIDS; 2016 Jan; 30(1):57-63. PubMed ID: 26372481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV.
    Matthews RP; Jackson Rudd D; Fillgrove KL; Zhang S; Tomek C; Stoch SA; Iwamoto M
    Clin Drug Investig; 2021 Jul; 41(7):629-638. PubMed ID: 34151413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
    Sanchez RI; Yee KL; Fan L; Cislak D; Martell M; Jordan HR; Iwamoto M; Khalilieh S
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):107-114. PubMed ID: 30973682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid-Reducing Agents.
    Khalilieh SG; Yee KL; Sanchez RI; Fan L; Vaynshteyn K; Deschamps K; Martell M; Jordan HR; Iwamoto M
    J Clin Pharmacol; 2019 Aug; 59(8):1093-1098. PubMed ID: 30817001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone.
    Khalilieh S; Yee KL; Sanchez RI; Vaynshteyn K; Fan L; Searle S; Bouhajib M; Iwamoto M
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):151-161. PubMed ID: 31120195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions.
    Khalilieh S; Yee KL; Sanchez R; Stoch SA; Wenning L; Iwamoto M
    Clin Drug Investig; 2020 Oct; 40(10):927-946. PubMed ID: 32816220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Siringhaus T; Herpok L; Bethel-Brown C; Manthos H; Brejda J; Gartner M
    Biopharm Drug Dispos; 2016 Dec; 37(9):542-549. PubMed ID: 27704562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir.
    Ankrom W; Sanchez RI; Yee KL; Fan L; Mitra P; Wolford D; Triantafyllou I; Sterling LM; Stoch SA; Iwamoto M; Khalilieh S
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions.
    Khalilieh SG; Yee KL; Sanchez RI; Fan L; Anderson MS; Sura M; Laethem T; Rasmussen S; van Bortel L; van Lancker G; Iwamoto M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.
    Yee KL; DiBenedetto A; Fan L; Khalilieh S; Triantafyllou I; Vallee MH; Fackler P; Stoch SA; Iwamoto M
    AAPS PharmSciTech; 2020 Feb; 21(3):91. PubMed ID: 32060665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin.
    Yee KL; Cabalu TD; Kuo Y; Fillgrove KL; Liu Y; Triantafyllou I; McClain S; Dreyer D; Wenning L; Stoch SA; Iwamoto M; Sanchez RI; Khalilieh SG
    J Clin Pharmacol; 2021 Mar; 61(3):394-405. PubMed ID: 32989795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.